Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 47

Results For "ALS"

7974 News Found

Alembic received 6 USFDA approvals during Q2FY24
Drug Approval | October 05, 2023

Alembic received 6 USFDA approvals during Q2FY24

The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets


Briefs: Aurobindo Pharma and Balaxi Pharmaceuticals
News | October 03, 2023

Briefs: Aurobindo Pharma and Balaxi Pharmaceuticals

Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company


Apollo Hospitals celebrates its leadership position as the largest Cardiac care programme in India
Healthcare | September 29, 2023

Apollo Hospitals celebrates its leadership position as the largest Cardiac care programme in India

Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries


Berhyanda gets nod for acquisition of up to 76.1% stake in Suven Pharmaceuticals
News | September 29, 2023

Berhyanda gets nod for acquisition of up to 76.1% stake in Suven Pharmaceuticals

The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company


Apollo Hospitals acquires partly built hospital in Sonarpur, Kolkata
News | September 28, 2023

Apollo Hospitals acquires partly built hospital in Sonarpur, Kolkata

The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months


27,353 hospitals empanelled under PM-JAY
Policy | September 26, 2023

27,353 hospitals empanelled under PM-JAY

30 beneficiaries avail of services per minute


Indraprastha Apollo Hospitals collaborates with MotoGP Bharat
News | September 25, 2023

Indraprastha Apollo Hospitals collaborates with MotoGP Bharat

The medical center at the Buddh International Circuit will be under the care of the Indraprastha Apollo Hospital team


Merck and Eisai update on Two Phase 3 Trials Evaluating Keytruda plus Lenima for cell lung cancer
Clinical Trials | September 23, 2023

Merck and Eisai update on Two Phase 3 Trials Evaluating Keytruda plus Lenima for cell lung cancer

The companies will work with investigators to share the results with the scientific community


Torque Pharmaceuticals launches campaign to celebrate World Pharmacist Day
News | September 22, 2023

Torque Pharmaceuticals launches campaign to celebrate World Pharmacist Day

The campaign for the digital film is being amplified across various digital media platforms such as YouTube, Facebook, Instagram, Twitter, and LinkedIn